Cetera Trust Company, N.A Astrazeneca PLC Transaction History
Cetera Trust Company, N.A
- $166 Billion
- Q1 2024
A detailed history of Cetera Trust Company, N.A transactions in Astrazeneca PLC stock. As of the latest transaction made, Cetera Trust Company, N.A holds 4,175 shares of AZN stock, worth $320,097. This represents 0.17% of its overall portfolio holdings.
Number of Shares
4,175
Previous 3,700
12.84%
Holding current value
$320,097
Previous $249 Million
13.51%
% of portfolio
0.17%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,250Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.7 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.77 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.29 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.65 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.32 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $238B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...